Company Filing History:
Years Active: 1998-2004
Title: Thomas E. Miller: Innovator in Nuclear Matrix Protein Assays
Introduction
Thomas E. Miller is a distinguished inventor based in Franklin, MA, who has made significant contributions to the field of biomedical diagnostics. With a total of six patents to his name, Miller's innovative work focuses on the detection and quantification of soluble nuclear matrix proteins, which play a crucial role in monitoring cellular viability and disease progression.
Latest Patents
One of Miller's latest patents is the Nuclear Matrix Protein Fluid Assay. This groundbreaking method enables the detection and quantitation of soluble nuclear matrix proteins found in body fluids and extracellular media. The significance of this method lies in its utility for monitoring the viability of cells and tissues, assessing the progress of diseases or their treatments, and evaluating the cytotoxicity of unknown compounds. Additionally, his patent discusses methods for inducing the release of nuclear matrix proteins in a soluble form from cells, further advancing the field of cellular diagnostics.
Career Highlights
Throughout his career, Thomas E. Miller has been associated with renowned companies such as Matritech, Inc. and has worked closely with influential figures such as Graham P. Lidgard and Lee Anne Beausang. His experience in these organizations has contributed to the development of innovative diagnostic methods, establishing him as a key figure in the field.
Collaborations
Miller's collaborations with colleagues like Graham P. Lidgard and Lee Anne Beausang have played a pivotal role in advancing research on nuclear matrix proteins. Their combined expertise has propelled the development of methods that hold promise for breakthroughs in understanding cell viability and disease monitoring.
Conclusion
In summary, Thomas E. Miller stands out as an innovative inventor whose work on nuclear matrix protein assays holds significant potential for improving diagnostic techniques in the biomedical field. His contributions not only enhance our understanding of cellular processes but also pave the way for more effective disease monitoring and treatment strategies.